Ecopipam Treatment of Self-Injurious Behavior in Subjects With Lesch-Nyhan Disease

NCT01751802 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

9

Enrollment

INDUSTRY

Sponsor class

Stopped Study terminated for commercial reasons

Conditions

Lesch-Nyhan Disease
Self-injurious Behavior

Interventions

DRUG: Ecopipam
DRUG: Placebo

Sponsor

Emalex Biosciences Inc.

Collaborators

[object Object]